U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Metro Vapors, LLC - 562955 - 11/14/2018
  1. Warning Letters

CLOSEOUT LETTER

Metro Vapors, LLC MARCS-CMS 562955 —

Delivery Method:
UPS and Electronic Mail
Recipient:
Recipient Name
Brandon Parrish
Metro Vapors, LLC
Metro Vapors, LLC

403 S. Highway 78
Wylie, TX 75098-3964
United States

info@metrovaporshop.com
Issuing Office:
Center for Tobacco Products

10903 New Hampshire Avenue
Silver Spring, MD 20993
United States

Dear Brandon Parrish:

On September 12, 2018, the United States Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) issued you a Warning Letter informing you that your Candy King Sour Worms e-liquid product is misbranded under section 903(a)(1) and/or 903(a)(7)(A) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because its labeling and/or advertising is false or misleading. Specifically, FDA determined that the labeling and/or advertising of your Candy King Sour Worms e-liquid is misleading under section 903(a)(1) and/or 903(a)(7)(A) of the FD&C Act because it causes the product to imitate food products, particularly ones that are marketed toward, and/or appealing to, children.

On October 1, 2018, you sent FDA a response to the Warning Letter, and we held a teleconference on November 8, 2018 to discuss the Warning Letter and your response. In response to the Warning Letter, you stated that you implemented corrective actions to address the violation identified in the Warning Letter. Based on our evaluation, it appears that you have taken steps to address the violation identified in the Warning Letter.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the FD&C Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Should you have any questions or concerns, please contact me at (301 ) 796-9235 or by email at elenita. ibarrapratt@fda. hhs.qov.

Sincerely,
/S/
Ele Ibarra-Pratt
Division Director
Office of Compliance and Enforcement
Center for Tobacco Products

cc:

Azim Chowdhury
Keller and Heckman LLP
1001 G Street NW, Suite 500 West
Washington, DC 20001
chowdhury@khlaw.com

Brandon Parrish
5736 Highway 78 Suite A
Sachse, TX 75048

Domains by Proxy, LLC
metrovaporshop.com@domainsbyproxy.com

GoDaddy.com, LLC
abuse@godaddy.com

BigCommerce Inc.
abuse@bigcommerce.com

Back to Top